Pages that link to "Q36141986"

The following pages link to A unique role of RGS9-2 in the striatum as a positive or negative regulator of opiate analgesia (Q36141986):

Displaying 39 items.

• μ-Opioid receptors and regulators of G protein signaling (RGS) proteins: from a symposium on new concepts in mu-opioid pharmacology (Q26991859) (← links)
• D1 dopamine receptor signaling is modulated by the R7 RGS protein EAT-16 and the R7 binding protein RSBP-1 in Caenoerhabditis elegans motor neurons (Q28483848) (← links)
• Association between regulator of G protein signaling 9-2 and body weight (Q28742338) (← links)
• Recent advances on the δ opioid receptor: from trafficking to function (Q34939664) (← links)
• Regulators of G protein signaling (RGS) proteins as drug targets: modulating G-protein-coupled receptor (GPCR) signal transduction (Q35523846) (← links)
• RGS9-2 modulates sensory and mood related symptoms of neuropathic pain (Q35695071) (← links)
• R7BP modulates opiate analgesia and tolerance but not withdrawal (Q35760250) (← links)
• RGS proteins as targets in the treatment of intestinal inflammation and visceral pain: New insights and future perspectives (Q35906057) (← links)
• RGS9-2--controlled adaptations in the striatum determine the onset of action and efficacy of antidepressants in neuropathic pain states (Q36056818) (← links)
• RGS10 exerts a neuroprotective role through the PKA/c-AMP response-element (CREB) pathway in dopaminergic neuron-like cells (Q36213563) (← links)
• Modulation of μ-opioid receptor signaling by RGS19 in SH-SY5Y cells (Q36573196) (← links)
• The complex of G protein regulator RGS9-2 and Gβ(5) controls sensitization and signaling kinetics of type 5 adenylyl cyclase in the striatum (Q36634572) (← links)
• Association with the Plasma Membrane Is Sufficient for Potentiating Catalytic Activity of Regulators of G Protein Signaling (RGS) Proteins of the R7 Subfamily (Q36727488) (← links)
• Molecular mechanisms of opioid receptor-dependent signaling and behavior (Q36974487) (← links)
• Differential control of opioid antinociception to thermal stimuli in a knock-in mouse expressing regulator of G-protein signaling-insensitive Gαo protein (Q37088994) (← links)
• Macromolecular composition dictates receptor and G protein selectivity of regulator of G protein signaling (RGS) 7 and 9-2 protein complexes in living cells (Q37132059) (← links)
• Mu opioid receptor activation enhances regulator of G protein signaling 4 association with the mu opioid receptor/G protein complex in a GTP-dependent manner (Q37279348) (← links)
• RGS6 as a Novel Therapeutic Target in CNS Diseases and Cancer. (Q37600399) (← links)
• Inhibition of the regulator of G protein signalling RGS4 in the spinal cord decreases neuropathic hyperalgesia and restores cannabinoid CB1 receptor signalling (Q37686101) (← links)
• Differential localization of G protein βγ subunits. (Q37731597) (← links)
• Evidence from basic research for opioid combinations (Q37999097) (← links)
• Opioid receptor interacting proteins and the control of opioid signaling. (Q38085387) (← links)
• Efficacy and ligand bias at the μ-opioid receptor (Q38104365) (← links)
• Nitric oxide and zinc-mediated protein assemblies involved in mu opioid receptor signaling. (Q38105951) (← links)
• Regulator of G-Protein Signaling 7 Regulates Reward Behavior by Controlling Opioid Signaling in the Striatum (Q38420812) (← links)
• RGS9-2 Modulates Responses to Oxycodone in Pain-Free and Chronic Pain States (Q39027669) (← links)
• Nucleus accumbens-specific interventions in RGS9-2 activity modulate responses to morphine (Q40777843) (← links)
• RGS9-2 modulates nociceptive behaviour and opioid-mediated synaptic transmission in the spinal dorsal horn. (Q42232684) (← links)
• Morphine epigenomically regulates behavior through alterations in histone H3 lysine 9 dimethylation in the nucleus accumbens (Q42393444) (← links)
• Evaluation of the Selectivity and Cysteine Dependence of Inhibitors across the Regulator of G Protein-Signaling Family (Q47626622) (← links)
• Quantitative Multiple-Reaction Monitoring Proteomic Analysis of Gβ and Gγ Subunits in C57Bl6/J Brain Synaptosomes. (Q47843802) (← links)
• Suppression of RGSz1 function optimizes the actions of opioid analgesics by mechanisms that involve the Wnt/β-catenin pathway. (Q50026534) (← links)
• Genetic Analysis of Rare Human Variants of Regulators of G Protein Signaling Proteins and Their Role in Human Physiology and Disease (Q57178844) (← links)
• Regulators of G-Protein Signaling (RGS) Proteins Promote Receptor Coupling to G-Protein-Coupled Inwardly Rectifying Potassium (GIRK) Channels (Q57284888) (← links)
• The in vivo specificity of synaptic Gβ and Gγ subunits to the α adrenergic receptor at CNS synapses (Q61797639) (← links)
• Selective Role of RGS9-2 in Regulating Retrograde Synaptic Signaling of Indirect Pathway Medium Spiny Neurons in Dorsal Striatum. (Q64986119) (← links)
• Regulator of G-Protein Signaling (RGS) Protein Modulation of Opioid Receptor Signaling as a Potential Target for Pain Management (Q89619696) (← links)
• Fentanyl: Receptor pharmacology, abuse potential, and implications for treatment (Q90351974) (← links)
• The Opioid Crisis and the Future of Addiction and Pain Therapeutics (Q93085802) (← links)